DE60022227D1 - 2-(1h-indol-3-yl)-2-oxo-acetamide mit antitumoraler wirkung - Google Patents
2-(1h-indol-3-yl)-2-oxo-acetamide mit antitumoraler wirkungInfo
- Publication number
- DE60022227D1 DE60022227D1 DE60022227T DE60022227T DE60022227D1 DE 60022227 D1 DE60022227 D1 DE 60022227D1 DE 60022227 T DE60022227 T DE 60022227T DE 60022227 T DE60022227 T DE 60022227T DE 60022227 D1 DE60022227 D1 DE 60022227D1
- Authority
- DE
- Germany
- Prior art keywords
- indol
- oxo
- acetamide
- antitumoral effect
- antitumoral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI992693 | 1999-12-23 | ||
IT1999MI002693A IT1315267B1 (it) | 1999-12-23 | 1999-12-23 | Derivati di 2-(1h-indol-3-il)-2-oxo-acetammidi ad attivita'antitumorale |
PCT/EP2000/013068 WO2001047916A1 (en) | 1999-12-23 | 2000-12-21 | 2-(1h-indol-3-yl)-2-oxo-acetamides with antitumor activity |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60022227D1 true DE60022227D1 (de) | 2005-09-29 |
DE60022227T2 DE60022227T2 (de) | 2006-06-22 |
Family
ID=11384182
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60022227T Expired - Fee Related DE60022227T2 (de) | 1999-12-23 | 2000-12-21 | 2-(1h-indol-3-yl)-2-oxo-acetamide mit antitumoraler wirkung |
Country Status (24)
Country | Link |
---|---|
US (1) | US6753342B2 (de) |
EP (1) | EP1244652B1 (de) |
JP (1) | JP2003519140A (de) |
KR (1) | KR100795533B1 (de) |
CN (1) | CN1250542C (de) |
AT (1) | ATE302772T1 (de) |
AU (1) | AU776332B2 (de) |
BR (1) | BR0016553A (de) |
CA (1) | CA2395205A1 (de) |
CZ (1) | CZ20022170A3 (de) |
DE (1) | DE60022227T2 (de) |
EA (1) | EA004925B1 (de) |
ES (1) | ES2246918T3 (de) |
HU (1) | HUP0203524A3 (de) |
IL (2) | IL150329A0 (de) |
IT (1) | IT1315267B1 (de) |
MX (1) | MXPA02006217A (de) |
NO (1) | NO323312B1 (de) |
NZ (1) | NZ519689A (de) |
PL (1) | PL356541A1 (de) |
SK (1) | SK285682B6 (de) |
TR (1) | TR200201613T2 (de) |
WO (1) | WO2001047916A1 (de) |
ZA (1) | ZA200204964B (de) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA59443C2 (uk) | 1998-04-28 | 2003-09-15 | Арцнайміттельверк Дрезден Гмбх | Гідроксііндол, спосіб його одержання, лікарська форма на його основі та спосіб її одержання |
IT1318641B1 (it) | 2000-07-25 | 2003-08-27 | Novuspharma Spa | Ammidi di acidi 2-(1h-indol-3-il)-2-oxo-acetici ad attivita'antitumorale. |
DE10037310A1 (de) * | 2000-07-28 | 2002-02-07 | Asta Medica Ag | Neue Indolderivate und deren Verwendung als Arzneimittel |
EA013371B1 (ru) * | 2002-07-09 | 2010-04-30 | Фасджен, Ллс. | Новые соединения, содержащие их фармацевтические композиции и способы их применения |
AU2004270733B2 (en) | 2003-09-11 | 2011-05-19 | Itherx Pharma, Inc. | Cytokine inhibitors |
EP1740171B1 (de) * | 2004-03-11 | 2010-06-09 | Actelion Pharmaceuticals Ltd. | Indol-1-yl-essigsäurederivate |
DK3091011T3 (en) | 2006-04-07 | 2018-02-26 | Vertex Pharma | MODULATORS OF ATP BINDING CASSETTE TRANSPORT |
US7645789B2 (en) | 2006-04-07 | 2010-01-12 | Vertex Pharmaceuticals Incorporated | Indole derivatives as CFTR modulators |
US10022352B2 (en) | 2006-04-07 | 2018-07-17 | Vertex Pharmaceuticals Incorporated | Modulators of ATP-binding cassette transporters |
EA018724B1 (ru) * | 2006-08-07 | 2013-10-30 | Айронвуд Фармасьютикалз, Инк. | Соединения индола |
US8563573B2 (en) | 2007-11-02 | 2013-10-22 | Vertex Pharmaceuticals Incorporated | Azaindole derivatives as CFTR modulators |
US8802868B2 (en) | 2010-03-25 | 2014-08-12 | Vertex Pharmaceuticals Incorporated | Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxo1-5-yl)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan2-yl)-1H-Indol-5-yl)-Cyclopropanecarboxamide |
SG184987A1 (en) | 2010-04-22 | 2012-11-29 | Vertex Pharma | Process of producing cycloalkylcarboxamido-indole compounds |
AR084433A1 (es) | 2010-12-22 | 2013-05-15 | Ironwood Pharmaceuticals Inc | Inhibidores de la faah y composiciones farmaceuticas que los contienen |
US9056851B2 (en) | 2011-03-25 | 2015-06-16 | The Research Foundation For The State University Of New York | Thiolactone antibiotics |
AU2013290444B2 (en) | 2012-07-16 | 2018-04-26 | Vertex Pharmaceuticals Incorporated | Pharmaceutical compositions of (R)-1-(2,2-diflurorbenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl) cyclopropanecarboxamide and administration thereof |
PL3925607T3 (pl) | 2014-04-15 | 2023-10-30 | Vertex Pharmaceuticals Incorporated | Kompozycje farmaceutyczne do leczenia chorób, w których pośredniczy mukowiscydozowy przezbłonowy regulator przewodnictwa |
CN115785079B (zh) * | 2022-11-28 | 2024-02-13 | 沈阳药科大学 | 4-(1h-吲哚-5-基)氨基呋喃-2(5h)-酮类化合物及其制备和应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AP866A (en) * | 1995-08-02 | 2000-08-17 | Newcastle Univ Ventures Limited | Benzimidazole compounds. |
CO4970714A1 (es) * | 1997-09-05 | 2000-11-07 | Boehringer Mannheim Gmbh | Derivados ureido y tioureido de 4-amino-2(5h)-furanonas y 4-amino-2(5h) tiofenonas como agentes antitumorales |
DE19814838C2 (de) | 1998-04-02 | 2001-01-18 | Asta Medica Ag | Indolyl-3-glyoxylsäure-Derivate mit Antitumorwirkung |
UA59443C2 (uk) * | 1998-04-28 | 2003-09-15 | Арцнайміттельверк Дрезден Гмбх | Гідроксііндол, спосіб його одержання, лікарська форма на його основі та спосіб її одержання |
-
1999
- 1999-12-23 IT IT1999MI002693A patent/IT1315267B1/it active
-
2000
- 2000-12-21 EP EP00985225A patent/EP1244652B1/de not_active Expired - Lifetime
- 2000-12-21 TR TR2002/01613T patent/TR200201613T2/xx unknown
- 2000-12-21 AT AT00985225T patent/ATE302772T1/de not_active IP Right Cessation
- 2000-12-21 IL IL15032900A patent/IL150329A0/xx active IP Right Grant
- 2000-12-21 ES ES00985225T patent/ES2246918T3/es not_active Expired - Lifetime
- 2000-12-21 CN CNB00817492XA patent/CN1250542C/zh not_active Expired - Fee Related
- 2000-12-21 EA EA200200558A patent/EA004925B1/ru not_active IP Right Cessation
- 2000-12-21 HU HU0203524A patent/HUP0203524A3/hu unknown
- 2000-12-21 AU AU21704/01A patent/AU776332B2/en not_active Ceased
- 2000-12-21 CZ CZ20022170A patent/CZ20022170A3/cs unknown
- 2000-12-21 CA CA002395205A patent/CA2395205A1/en not_active Abandoned
- 2000-12-21 SK SK896-2002A patent/SK285682B6/sk not_active IP Right Cessation
- 2000-12-21 US US10/149,406 patent/US6753342B2/en not_active Expired - Fee Related
- 2000-12-21 WO PCT/EP2000/013068 patent/WO2001047916A1/en active IP Right Grant
- 2000-12-21 PL PL00356541A patent/PL356541A1/xx not_active IP Right Cessation
- 2000-12-21 DE DE60022227T patent/DE60022227T2/de not_active Expired - Fee Related
- 2000-12-21 KR KR1020027007960A patent/KR100795533B1/ko not_active IP Right Cessation
- 2000-12-21 BR BR0016553-0A patent/BR0016553A/pt not_active Application Discontinuation
- 2000-12-21 JP JP2001549386A patent/JP2003519140A/ja active Pending
- 2000-12-21 NZ NZ519689A patent/NZ519689A/en unknown
- 2000-12-21 MX MXPA02006217A patent/MXPA02006217A/es active IP Right Grant
-
2002
- 2002-06-19 IL IL150329A patent/IL150329A/en not_active IP Right Cessation
- 2002-06-20 NO NO20022976A patent/NO323312B1/no not_active IP Right Cessation
- 2002-06-20 ZA ZA200204964A patent/ZA200204964B/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60022227D1 (de) | 2-(1h-indol-3-yl)-2-oxo-acetamide mit antitumoraler wirkung | |
DE69918422D1 (de) | Phthalazinone pde iii/iv hemmer | |
ES2196396T3 (es) | Compuestos heteroaromaticos de 5 miembros conteniendo oxigeno o azufre como inhibidores del factor xa. | |
TR199901653T2 (xx) | Fitalazinonlar. | |
ATE258930T1 (de) | Dihydrobenzifurane | |
MY128709A (en) | Phosphonites | |
PT1086096E (pt) | Benzamidas com substituintes etra-hidrofuraniloxi como inibidores da fosfodiesterase 4 | |
DE60005689D1 (de) | Neue aminobenzophenone | |
SE9903290D0 (sv) | Novel compounds | |
DK1377574T3 (da) | 6-phenylbenzonaphtyridiner | |
ATE330958T1 (de) | Pyrazino 1'2':1,6öpyrido 3,4-böindolderivate | |
MXPA04000506A (es) | Nuevos derivados de et-743 antitumorales. | |
MA24197A1 (fr) | Nouvelles fungarrestines | |
ES2159489A1 (es) | Nuevos derivados de imidazol con actividad antiinflamatoria. | |
DE59803066D1 (de) | Substituierte benzyloxyimino-verbindungen | |
ATE243698T1 (de) | 1,2-dihydro-1-oxo-pyrazino(1,2-)indolederivate | |
ID27656A (id) | Turunan azabisikloheptana n-tersubstitusi, pembuatan dan penggunaannya | |
ES2166710A1 (es) | Nuevos compuestos heterociclicos con actividad antiinflamatoria. | |
DE59905355D1 (de) | Verwendung von katecholderivaten als proteinaseinhibitoren | |
CY1110529T1 (el) | Παρασκευη ν-υποκατεστημενων 2,7-διαλκυλο-4-υδροξυ-5-αμινο-8-αρυλοοκτανοϋλαμιδιων | |
DE602004018276D1 (de) | Nitratester von phenylaminothiophen-essigsäurederivaten | |
CY1110467T1 (el) | 2-(ετερο-)αρυλιο υποκατεστημενα παραγωγα τετραϋδροκινολινης |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |